doi.bio/dinko_franceschi

Dinko Franceschi

Dinko Franceschi, MD, is a board-certified nuclear medicine physician and radiologist. He is currently an associate professor of radiology at Stony Brook University SOM in New York and is affiliated with multiple hospitals in the area, including Stony Brook University Hospital and St. Charles Hospital.

Education and Training

Franceschi received his medical degree from the University of Zagreb Faculty of Medicine. He completed Nuclear Medicine Residencies at Johns Hopkins University School of Medicine and Brigham and Women's Hospital/Harvard Medical School. He then went on to complete a Nuclear Medicine Fellowship at Stony Brook Medicine, where he served as Chief of Nuclear Medicine and Director of Clinical PET in the Department of Radiology.

Research and Publications

Franceschi has numerous publications in the field of nuclear medicine and radiology. Some of his notable publications include:

"Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise" in the Journal of Nuclear Medicine (2018)
"Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer" in the Journal of Nuclear Medicine (2020)
"Extensive Nonsegmental Pulmonary Perfusion Defects on SPECT/CT as an Early Sign of COVID-19 Infection" in the World Journal of Nuclear Medicine (2022)
"Modulation of Secondary Cancer Risks from Radiation Exposure by Sex, Age and Gonadal Hormone Status: Progress, Opportunities and Challenges" in the Journal of Personalized Medicine (2022)

In addition to his clinical work, Franceschi has also been involved in research at Harvard Medical School, where he used probabilistic modeling to study the effects of genetic variation on disease. He has also worked on human gene regulation at the Broad Institute of MIT and Harvard.

Awards and Recognition

Magna cum laude graduate, Columbia University
Columbia University Honor Society

- Dean's List at Columbia University

Dr. Dinko Franceschi

Overview

Dr. Dinko Franceschi is a board-certified nuclear medicine physician with over 20 years of experience. He is currently licensed to practice medicine in New York and Vermont and is affiliated with Stony Brook University Hospital, St. Charles Hospital, and Northport Veterans Affairs Medical Center.

Education & Training

Dr. Franceschi received his medical degree from the University of Zagreb Faculty of Medicine. He completed Nuclear Medicine Residencies at Johns Hopkins University School of Medicine and Brigham and Women's Hospital/Harvard Medical School. He then completed his Nuclear Medicine Fellowship at Stony Brook Medicine, where he served as Chief of Nuclear Medicine and Director of Clinical PET in the Department of Radiology.

Publications & Research

Dr. Franceschi has numerous publications in the field of nuclear medicine and imaging, including:

Deep generative modeling of the human proteome reveals over a hundred novel genes involved in rare genetic disorders (Orenbuch et al., 2024)
ProteinGym: Large-Scale Benchmarks for Protein Design and Fitness Prediction (Notin et al., 2023)
A conformal TOF-DOI Prism-PET prototype scanner for high-resolution quantitative neuroimaging (Zeng et al., 2023)
Extensive Nonsegmental Pulmonary Perfusion Defects on SPECT/CT as an Early Sign of COVID-19 Infection (A. Franceschi et al., 2022)
Modulation of Secondary Cancer Risks from Radiation Exposure by Sex, Age and Gonadal Hormone Status: Progress, Opportunities and Challenges (Biegon, Cohen, & Franceschi, 2022)
Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise (Biegon, Franceschi, & Schweitzer, 2018)